112 related articles for article (PubMed ID: 34897615)
1. Preoperative Thrombocytosis is Not Associated with Overall Survival in 309 Glioblastoma Patients.
Marx S; Altmann R; Baschin M; Paland H; Rauch B; Kohlmann T; Schroeder HWS
J Neurol Surg A Cent Eur Neurosurg; 2022 Nov; 83(6):548-554. PubMed ID: 34897615
[TBL] [Abstract][Full Text] [Related]
2. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.
Brockmann MA; Giese A; Mueller K; Kaba FJ; Lohr F; Weiss C; Gottschalk S; Nolte I; Leppert J; Tuettenberg J; Groden C
Neuro Oncol; 2007 Jul; 9(3):335-42. PubMed ID: 17504931
[TBL] [Abstract][Full Text] [Related]
3. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
4. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
5. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
[TBL] [Abstract][Full Text] [Related]
6. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
8. Tumor-platelet interactions: glioblastoma growth is accompanied by increasing platelet counts.
Nolte I; Przibylla H; Bostel T; Groden C; Brockmann MA
Clin Neurol Neurosurg; 2008 Apr; 110(4):339-42. PubMed ID: 18243523
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
10. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
11. Primary glioblastoma multiforme in younger patients: a single-institution experience.
Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative controlling nutritional status in patients with glioblastoma.
Hu C; Chen K; Tang X
Clin Neurol Neurosurg; 2020 Nov; 198():106129. PubMed ID: 32823182
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
[TBL] [Abstract][Full Text] [Related]
15. Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.
Schwartz C; Romagna A; Stefanits H; Zimmermann G; Ladisich B; Geiger P; Rechberger J; Winkler S; Weiss L; Fastner G; Trinka E; Weis S; Spiegl-Kreinecker S; Steinbacher J; McCoy M; Johannes T; Gruber A; Rezai Jahromi B; Niemelä M; Winkler PA; Thon N
World Neurosurg; 2020 Jan; 133():e583-e591. PubMed ID: 31561040
[TBL] [Abstract][Full Text] [Related]
16. Safety and outcomes of resection of butterfly glioblastoma.
Dayani F; Young JS; Bonte A; Chang EF; Theodosopoulos P; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E4. PubMed ID: 29852771
[TBL] [Abstract][Full Text] [Related]
17. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
Lacroix M; Abi-Said D; Fourney DR; Gokaslan ZL; Shi W; DeMonte F; Lang FF; McCutcheon IE; Hassenbusch SJ; Holland E; Hess K; Michael C; Miller D; Sawaya R
J Neurosurg; 2001 Aug; 95(2):190-8. PubMed ID: 11780887
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article.
Chaichana KL; Chaichana KK; Olivi A; Weingart JD; Bennett R; Brem H; Quiñones-Hinojosa A
J Neurosurg; 2011 Mar; 114(3):587-94. PubMed ID: 20887095
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
20. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
